Literature DB >> 32312529

Oral cancer in a 5-year-old boy: a rare case report and review of literature.

Nathan V Lee1, Erh Tung Ben Kang2, Christof Senger3, Catherine F Poh4.   

Abstract

Oral cancer in children is rare. Diagnosis may be delayed as a result of confusion with reactive lesions. Furthermore, cancer staging, with or without bony invasion, can be complicated during tooth eruption. Literature on pediatric oral cancers is lacking, making determination of the possible etiopathology difficult. We describe an exceptional case of a 5-year-old male child who presented with anterior maxillary gingival pseudoepitheliomatous hyperplasia that progressed to carcinoma cuniculatum with invasive oral squamous cell carcinoma (OSCC). Because of the interesting timing of events, we hypothesize that human papillomavirus (HPV) inoculation through cutaneous squamous papilloma played a contributory role. A review of similar case reports in the literature is included. Biopsy of suspicious oral lesions should not be delayed because of the young age of the patient. Atypical hyperplasia should include squamous cell carcinoma (SCC) in the differential diagnoses. For surgical management of aggressive lesions during the mixed dentition, permanent successors should be included in the surgical margins to prevent recurrence.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Year:  2020        PMID: 32312529     DOI: 10.1016/j.oooo.2019.12.005

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  2 in total

1.  Mutation Analysis of Second Primary Tumors in Oral Cancer in Taiwanese Patients through Next-Generation Sequencing.

Authors:  Ting-Yuan Liu; Chien-Chin Lee; Yu-Chia Chen; Ya-Sian Chang; Hsi-Yuan Huang; Ya-Ting Lee; Ju-Chen Yen; Dysan Chao; Jan-Gowth Chang
Journal:  Diagnostics (Basel)       Date:  2022-04-11

2.  Carcinoma cuniculatum in maxillary gingiva mimicking verruciform xanthoma: a case report.

Authors:  Dongmei Jia; Yanhua Yang; Siqi Xu; Chen Jiang
Journal:  Transl Cancer Res       Date:  2021-10       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.